Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
17.44 USD | +1.81% | +1.69% | +59.51% |
May. 10 | Wedbush Raises Edgewise Therapeutics' PT to $31 From $26, Keeps Outperform Rating | MT |
May. 09 | Edgewise Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+59.51% | 1.6B | |
+49.04% | 54.63B | |
-6.20% | 39.92B | |
+37.07% | 38.82B | |
+14.09% | 26.86B | |
-11.17% | 26.22B | |
-21.52% | 18.78B | |
+25.87% | 12.21B | |
+1.05% | 12.16B | |
+26.30% | 11.94B |
- Stock Market
- Equities
- EWTX Stock
- News Edgewise Therapeutics, Inc.
- Wedbush Raises Edgewise Therapeutics' PT to $31 From $26, Keeps Outperform Rating